COVID-19 and Securities Laws: A Contemporary Legal Issue
Keywords:
Laws, COVID-19, securities, disease, pandemicAbstract
COVID-19 pandemic is the present global problem. The new disease already attacks all continent and more than 100 million infected persons has already been recorded worldwide since its first appearance in 2019. The legal correspondence to the emerging disease is an interesting issue. Regarding COVID-19, there are many legal control measures for diseases containment. The objective of this article is to give an overview on COVID-19 outbreak and securities laws interrelationship. The retrospective literature analysis on the international publication regarding COVID-19 outbreak and legal containment is done. In this specific article, the authors discuss on specific securities laws for legal control of COVID-19. The finding from this study shows that there are advantages of legal measures for management of pandemic but there are still possible adverse effects of legal measure implementation. The utility of this work is a note for further of requirement for weighing between utility and possible side effect of the new laws. Nevertheless, since there are still limited reports on impact securities laws for COVID-19 containment, the additional monitoring of future literatures for fulfilling the knowledge gap is required.
References
1. Yasuhara J, Kuno T, Takagi H, Sumitomo N. Clinical characteristics of COVID-19 in children: A systematic review. Pediatr Pulmonol. 2020 Oct;55(10):2565–2575
2. Stasi C, Fallani S, Voller F, Silvestri C. Treatment for COVID -19: An overview. Eur J Pharmacol. 2020 Dec 15;889:173644.
3. Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID -19: Discovery, diagnostics and drug development. J Hepatol. 2021 Jan;74(1):168–184.
4. Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020 Dec 17;383(25):2451–2460.
5. Coghlan N, Archard D, Sipanoun P, Hayes T, Baharlo B. COVID -19: legal implications for critical care. Anaesthesia. 2020 Nov;75(11):1517–1528.
6. Finch J. Legal aspects of COVID -19 pandemic management for community nurses. Br J Community Nurs. 2020 Apr 2;25(4):196–199.
7. Merks P, Jakubowska M, Drelich E, Świeczkowski D, Bogusz J, Bilmin K, Sola KF, May A, Majchrowska A, Koziol M, Pawlikowski J, Jaguszewski M, Vaillancourt R. The legal extension of the role of pharmacists in light of the COVID- COVID-19 and Securities Laws: A Contemporary Legal Issue Mungmunpuntipantip and Wiwnaitkit JCMSL (2020) 22–25 © Law Journals 2020. All Rights Reserved Page 25 19 global pandemic. Re s Social Adm Pharm. 2021 Jan;17(1):1807–1812.
8. Arimany-Manso J, Martin -Fumadó C. Medico-legal issues regarding from the COVID-19 pandemic. Med Clin (Barc). 2020 Oct 23;155(8):344–346.
9. Hübner J, Schewe DM, Katalinic A, Frielitz FS. Legal Issues of Resource Allocation in the COVID -19 Pandemic Between Utilitarianism and Life Value Indifference. Dtsch Med Wochenschr. 2020 May;145(10):687–692.
10. Peixoto VR, Mexia R, Santos NS, Carvalho C, Abrantes A. From Tuberculosis to COVID -19: Legal and Constitutional Framework Regarding Compulsory Isolation/Treatment due to Contagious Diseases in Portugal. Acta Med Port. 2020 Apr 1;33(4):225–228.
11. Vokinger KN, Nittas V, Witt CM, Fabrikant SI, von Wyl V. Digital health and the COVID -19 epidemic: an assessment framework for apps f rom an epidemiological and legal perspective. Swiss Med Wkly. 2020 May 17;150: w20282.
12. Garcia MVF, Garcia MAF. Telemedicine, legal certainty, and COVID -19: where are we? J Bras Pneumol. 2020;46(4): e20200363.
13. Cohen IG, Crespo AM, White DB. Potential Legal Liability for Withdrawing or Withholding Ventilators During COVID-19: Assessing the Risks and Identifying Needed Reforms. JAMA. 2020 May 19;323(19):1901–1902.
14. Horchani F. Legal foundations of the fight against COVID -19. Tunis Med. 2020 Apr;98(4):309–311.
15. Al-Azri NH. Healthcare workers' legal liability and immunity during the COVID - 19 pandemic. Disaster Med Public Health Prep. 2020 Nov 19:1–8.
16. Klitzman RL. Legal Immunity for Physicians during the COVID -19 Pandemic: Needs to Address Legal and Ethical Challeng es. Chest. 2020 Oct;158(4):1343–1345.
17. Gostin LO, Friedman EA, Wetter SA. Responding to Covid-19: How to Navigate a Public Health Emergency Legally and Ethically. Hastings Cent Rep. 2020 Mar;50(2):8–12.
18. Kaplan B. Revisiting Health Information Technology Ethical, Legal, and Social Issues and Evaluation: Telehealth/ Telemedicine and COVID -19. Int J Med Inform. 2020 Nov;143:104239.
19. Bachireddy C, Chen C, Dar M. Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid's Response to COVI D-19. JAMA. 2020 May 26;323(20):2009–2010.
20. Williams CM, Chaturvedi R, Chakravarthy K. Cybersecurity Risks in a Pandemic. J Med Internet Res. 2020 Sep 17;22(9):e23692.
21. Bhate C, Ho CH, Brodell RT. Time to revisit the Health Insurance Portability and Accountability Act (HIPAA)? Accelerated telehealth adoption during the COVID -19 pandemic. J Am Acad Dermatol. 2020 Oct;83(4):e313-e314.
22. Wiwanitkit V. Editorial: “No case” as case study, a focus on COVID -19. Case Study Case Rep. 2020; 10(2): 22–23.
23. Gerke S, Shachar C, Chai PR, Cohen IG. Regulatory, safety, and privacy concerns of home monitoring technologies during COVID-19. Nat Med. 2020 Aug;26 (8):1176–1182. Cite this Article Rujittika Mungmunp untipantip, Viroj Wiwnaitkit. COVID-19 and Securities Laws: A Contemporary Legal Issue . Law. 2020; 3(2): 22–25p.
